{"id":{"repo_id":"wvu","oai_identifier":"oai:researchrepository.wvu.edu:etd-1623"},"canonical_url":"https://search.dev.ndltd.org/etd/wvu/oai:researchrepository.wvu.edu:etd-1623","repository":{"repo_id":"wvu","name":"West Virginia University","base_url":"https://researchrepository.wvu.edu/do/oai/"},"display":{"title":"A streptozotocin-induced model of Alzheimer's disease in mice with wild-type human tau","abstract":"Alzheimer's disease (AD) accounts for 60 to 80% of all dementias, affects over 5 million Americans, and incurs annual healthcare costs of over {dollar}200 billion (Alzheimer's Association, 2012). Hyperphosphorylation of tau, the main component of neurofibrillary tangles observed in AD, leads to deficits in cell structure and function. Because recent data suggest impairments in cerebral glucose utilization and energy metabolism play a prominent role in the pathogenesis of AD, we sought to create a mouse model that emulates the metabolic changes using intracerebroventricular infusions of streptozotocin (ICV-STZ) in transgenic mice expressing human tau. The Barnes maze, a test of spatial learning and memory, and a panel of antibodies directed at biochemical changes in tau associated with AD were used to assess memory deficits and tau pathology, respectively. The behavioral and biochemical findings of the current study provide inconsistent support for the use of an ICV-STZ model in mice expressing human tau, and future studies should employ a battery of behavioral assays to determine if subtle memory deficits occur.","abstract_html":"Alzheimer's disease (AD) accounts for 60 to 80% of all dementias, affects over 5 million Americans, and incurs annual healthcare costs of over {dollar}200 billion (Alzheimer's Association, 2012). Hyperphosphorylation of tau, the main component of neurofibrillary tangles observed in AD, leads to deficits in cell structure and function. Because recent data suggest impairments in cerebral glucose utilization and energy metabolism play a prominent role in the pathogenesis of AD, we sought to create a mouse model that emulates the metabolic changes using intracerebroventricular infusions of streptozotocin (ICV-STZ) in transgenic mice expressing human tau. The Barnes maze, a test of spatial learning and memory, and a panel of antibodies directed at biochemical changes in tau associated with AD were used to assess memory deficits and tau pathology, respectively. The behavioral and biochemical findings of the current study provide inconsistent support for the use of an ICV-STZ model in mice expressing human tau, and future studies should employ a battery of behavioral assays to determine if subtle memory deficits occur.","abstract_has_math":false,"creators":["Rudy, Carolyn C."],"institution":null,"degree_name":"MS","degree_level":"Thesis","degree_discipline":"Psychology","degree_department":null,"school":null,"contributors":["Miranda N. Reed","Karen G. Anderson","Steven G. Kinsey"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-05-01T07:00:00Z","date_published":"2014-05-01T07:00:00Z","updated_at":"2026-07-24T06:14:46Z","subjects":["Neurosciences","Biochemistry","Behavioral sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://researchrepository.wvu.edu/etd/620"],"render_values":[{"text":"https://researchrepository.wvu.edu/etd/620","href":"https://researchrepository.wvu.edu/etd/620","code":true}]}]},"links":{"outbound_url":"https://doi.org/10.33915/etd.620","outbound_label":"DOI","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Miranda N. Reed","Karen G. Anderson","Steven G. Kinsey"]},{"key":"dc:creator","label":"Author","values":["Rudy, Carolyn C."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2019-01-17T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Psychology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Neurosciences","Biochemistry","Behavioral sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://doi.org/10.33915/etd.620","https://researchrepository.wvu.edu/etd/620"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Alzheimer's disease (AD) accounts for 60 to 80% of all dementias, affects over 5 million Americans, and incurs annual healthcare costs of over {dollar}200 billion (Alzheimer's Association, 2012). Hyperphosphorylation of tau, the main component of neurofibrillary tangles observed in AD, leads to deficits in cell structure and function. Because recent data suggest impairments in cerebral glucose utilization and energy metabolism play a prominent role in the pathogenesis of AD, we sought to create a mouse model that emulates the metabolic changes using intracerebroventricular infusions of streptozotocin (ICV-STZ) in transgenic mice expressing human tau. The Barnes maze, a test of spatial learning and memory, and a panel of antibodies directed at biochemical changes in tau associated with AD were used to assess memory deficits and tau pathology, respectively. The behavioral and biochemical findings of the current study provide inconsistent support for the use of an ICV-STZ model in mice expressing human tau, and future studies should employ a battery of behavioral assays to determine if subtle memory deficits occur."]},{"key":"dc:title","label":"Title","values":["A streptozotocin-induced model of Alzheimer's disease in mice with wild-type human tau"]}]}],"canonical_facts":{"dc:contributor":["Miranda N. Reed","Karen G. Anderson","Steven G. Kinsey"],"dc:creator":["Rudy, Carolyn C."],"dc:date.available":["2019-01-17T08:00:00Z"],"dc:description.abstract":["Alzheimer's disease (AD) accounts for 60 to 80% of all dementias, affects over 5 million Americans, and incurs annual healthcare costs of over {dollar}200 billion (Alzheimer's Association, 2012). Hyperphosphorylation of tau, the main component of neurofibrillary tangles observed in AD, leads to deficits in cell structure and function. Because recent data suggest impairments in cerebral glucose utilization and energy metabolism play a prominent role in the pathogenesis of AD, we sought to create a mouse model that emulates the metabolic changes using intracerebroventricular infusions of streptozotocin (ICV-STZ) in transgenic mice expressing human tau. The Barnes maze, a test of spatial learning and memory, and a panel of antibodies directed at biochemical changes in tau associated with AD were used to assess memory deficits and tau pathology, respectively. The behavioral and biochemical findings of the current study provide inconsistent support for the use of an ICV-STZ model in mice expressing human tau, and future studies should employ a battery of behavioral assays to determine if subtle memory deficits occur."],"dc:identifier":["https://doi.org/10.33915/etd.620","https://researchrepository.wvu.edu/etd/620"],"dc:subject":["Neurosciences","Biochemistry","Behavioral sciences"],"dc:title":["A streptozotocin-induced model of Alzheimer's disease in mice with wild-type human tau"],"thesis:degree_discipline":["Psychology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["MS"]},"updated_at":"2026-07-24T06:14:46Z"}